AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
23:05
Rareș Bogdan: 25 Liberals Support the Luca Niculescu Government, and the Number Could Reach 27–28
22:44
Russia attacked Kharkiv's energy infrastructure after Trump's announcement regarding the energy truce
22:20
The US threatens to halt Ukraine’s arms purchases if attacks on Russia’s energy infrastructure continue
22:04
Emmanuel Macron supports the energy ceasefire between Russia and Ukraine
21:44
Raphaël Glucksmann to run in France’s presidential election / He won the left’s primary by a wide margin
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
IT&C knowledge
OpenAI abandons plans to go public in 2026 / Sam Altman: “It would be an inappropriate time”
Economy
The shares of companies on the Bucharest Stock Exchange can be traded through Interactive Brokers.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
